CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Change of serum albumin and risk of cardiovascular disease and all-cause mortality
Authors
L.M. Bouter
M.A. Bremmer
+4 more
D.J.H. Deeg
B.W.J.H. Penninx
B.W.M. Schalk
M. Visser
Publication date
1 January 2006
Publisher
Doi
Cite
Abstract
The aim of this longitudinal study was to investigate 3-year change in serum albumin concentration as a determinant of incident cardiovascular disease (CVD) and all-cause mortality. Data were from 713 respondents of the Longitudinal Aging Study Amsterdam initially aged 55-85 years. Serum albumin was measured at baseline (1992/1993) and after 3 years. At the 6-year follow-up, incident CVD (among 456 respondents with no prevalent CVD at the 3-year follow-up) and all-cause mortality were ascertained. Overall, 18.9% developed CVD and 10.9% died. After adjustment for potential confounders, a higher level of serum albumin at the 3-year follow-up was associated with a lower risk for incident CVD (relative risk = 0.88, 95% confidence interval (CI): 0.79, 0.98). The risk of incident CVD was 0.88 (95% CI: 0.78, 0.99) per unit (g/liter) increase in change in albumin between 3-year follow-up and baseline. Chronic low serum albumin (≤43 g/liter at baseline and 3-year follow-up) was not associated with incident CVD (p = 0.22). A clinically relevant decrease in serum albumin (≥1 standard deviation (2.5 g/liter) between baseline and 3-year follow-up) tended to be associated with a twofold risk (relative risk = 2.00, 95% CI: 0.91, 4.39). For all-cause mortality, no associations were observed. These findings suggest that older persons with a decrease in serum albumin concentration, even within the normal range, might be at increased risk of incident CVD. Change in serum albumin may be used as an early marker for CVD risk. Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health. All rights reserved
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
NARCIS
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 14/10/2017
VU Research Portal
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:research.vu.nl:publication...
Last time updated on 18/04/2020
DSpace at VU
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dare.ubvu.vu.nl:1871/22234
Last time updated on 03/09/2013
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 16/02/2019
NARCIS
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 31/03/2019